Presentation TCT 2013 TCT-69. Safety and clinical performance of the drug eluting Orsiro stent in patients with single de novo coronary artery lesions – II (BIOFLOW-II) -A quantitative analysis by IV... Presenter: Thierry Lefevre October 29, 2013
Presentation TCT 2013 Screening a Patient in the Supermarket Presenter: David Albert October 29, 2013
Presentation TCT 2013 All Novel Agents are Preferred to Warfarin Presenter: Michael Ezekowitz October 29, 2013
Presentation TCT 2013 Silent Atrial Fibrillation: An Under-Appreciated Threat Presenter: Taya Glotzer October 29, 2013
Presentation TCT 2013 TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO... Presenter: Takashi Muramatsu October 29, 2013
Presentation TCT 2013 The Need for Screening for Atrial Fibrillation Presenter: David Albert October 29, 2013
Presentation TCT 2013 Procedural Experience and Outcomes in the CoreValve US Extreme Risk Study Presenter: Michael Reardon October 29, 2013
Presentation Technical Overview of the Direct Flow Medical System Presenter: Federico De Marco October 29, 2013
Presentation Coronary Calcification: Insights from Angiography, IVUS, and OCT Presenter: Gary Mintz October 29, 2013